Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-09T22:30:51.630Z Has data issue: false hasContentIssue false

Chapter 17 - Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study

from Section 5 - Psychopharmacology

Published online by Cambridge University Press:  19 October 2021

By
Jan Volavka ,
Pál Czobor ,
Leslie Citrome  and
Richard A. Van Dorn
Edited by
Katherine D. Warburton  and
Stephen M. Stahl
Katherine D. Warburton
Affiliation:
University of California, Davis
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Violence in Psychiatry , pp. 177 - 186
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Volavka, J. Neurobiology of Violence, 2nd edn. Washington, DC: American Psychiatric Publishing, Inc.; 2002.Google Scholar
Stroup, TS, McEvoy, JP, Swartz, MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr. Bull. 2003; 29(1): 15–31.Google Scholar
Lieberman, JA, Stroup, TS, McEvoy, JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005; 353(12): 1209–1223.Google Scholar
Swanson, JW, Swartz, MS, Van Dorn, RA, et al. A national study of violent behavior in persons with schizophrenia. Arch. Gen. Psychiatry. 2006; 63(5): 490–499.Google Scholar
Fazel, S, Langstrom, N, Hjern, A, Grann, M, Lichtenstein, P. Schizophrenia, substance abuse, and violent crime. JAMA. 2009; 301(19): 2016–2023.CrossRefGoogle ScholarPubMed
Kay, SR, Opler, LA, Lindenmayer, JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br. J. Psychiatry. 1989; 155(Suppl 7): 59–65.CrossRefGoogle Scholar
Witt, K, van Dorn, R, Fazel, S. Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. PLoS One. 2013; 8(2): e55942.Google Scholar
Volavka, J, Czobor, P, Derks, EM, et al. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). J. Clin. Psychiatry. 2011; 72(7): 955–961.CrossRefGoogle ScholarPubMed
Kay, SR, Opler, LA, Fiszbein, A. Positive and Negative Syndrome Scale (PANSS) rating manual. 1986. Unpublished work.Google Scholar
Little, RC, Milliken, GA, Stroup, WW, Wolfinger, RD, Schabenberger, O. SAS for Mixed Models, 2nd edn. Cary, NC: SAS Press; 2006.Google Scholar
Swanson, JW, Swartz, MS, Van Dorn, RA, et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br. J. Psychiatry. 2008; 193(1): 37–43.Google Scholar
Krakowski, MI, Czobor, P, Citrome, L, Bark, N, Cooper, TB. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry. 2006; 63(6): 622–629.CrossRefGoogle ScholarPubMed
Citrome, L, Volavka, J, Czobor, P, et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility in treatment resistant patients with schizophrenia and schizoaffective disorder. Psychiatr. Serv. 2001; 52(11): 1510–1514.CrossRefGoogle Scholar
Czobor, P, Volavka, J, Meibach, RC. Effect of risperidone on hostility in schizophrenia. J. Clin. Psychopharmacol. 1995; 15(4): 243–249.CrossRefGoogle ScholarPubMed
Volavka, J, Czobor, P, Citrome, L, et al. Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies. J. Clin. Psychiatry. 2005; 66(11): 1362–1366.CrossRefGoogle ScholarPubMed
Citrome, L, Volavka, J, Czobor, P, et al. Efficacy of ziprasidone against hostility in schizophrenia: post hoc analysis of randomized, openlabel study data. J. Clin. Psychiatry. 2006; 67(4): 638–642.Google Scholar
Kinon, BJ, Roychowdhury, SM, Milton, DR, Hill, AL. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. J. Clin. Psychiatry. 2001; 62(Suppl 2): 17–21.Google Scholar
Arango, C, Bernardo, M. The effect of quetiapine on aggression and hostility in patients with schizophrenia. Hum. Psychopharmacol. 2005; 20(4): 237–241.CrossRefGoogle ScholarPubMed
Chengappa, KN, Goldstein, JM, Greenwood, M, John, V, Levine, J. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin. Ther. 2003; 25(2): 530–541.Google Scholar
Volavka, J, Swanson, JW, Citrome, LL. Understanding and managing violence in schizophrenia. In: Lieberman, JA, Murray, RM, eds. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management, 2nd edn. New York: Oxford University Press; 2012: 262–290.Google Scholar
Geddes, J, Freemantle, N, Harrison, P, Bebbington, P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000; 321(7273): 1371–1376.Google Scholar
Moller, HJ. Do effectiveness (“real world”) studies on antipsychotics tell us the real truth? Eur. Arch. Psychiatry Clin. Neurosci. 2008; 258(5): 257–270.Google Scholar
Kinon, BJ, Volavka, J, Stauffer, V, et al. Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. J. Clin. Psychopharmacol. 2008; 28(4): 392–400.CrossRefGoogle ScholarPubMed
Citrome, L, Holt, RI, Walker, DJ, Hoffmann, VP. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. Clin. Drug Investig. 2011; 31(7): 455–482.CrossRefGoogle ScholarPubMed
Volavka, J, Citrome, L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int. J. Clin. Pract. 2008; 62(8): 1237–1245.Google Scholar
Swanson, JW, Van Dorn, RA, Swartz, MS, et al. Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behavior problems. Law Hum. Behav. 2008; 32(3): 228–240.Google Scholar
Laajasalo, T, Salenius, S, Lindberg, N, Repo-Tiihonen, E, Hakkanen-Nyholm, H. Psychopathic traits in Finnish homicide offenders with schizophrenia. Int. J. Law Psychiatry. 2011; 34(3–4): 324–330.Google Scholar
Abushua’leh, K, bu-Akel, A. Association of psychopathic traits and symptomatology with violence in patients with schizophrenia. Psychiatry Res. 2006; 143(2–3): 205–211.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×